TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.

Richard L Piekarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.